Dec 18 (Reuters) - Novo Holdings has completed its $16.5
billion takeover of Catalent ( CTLT ), the contract drug
manufacturer announced on Wednesday, days after the companies
said all regulatory closing conditions were fulfilled.
Novo Holdings is the controlling shareholder of Danish
drugmaker Novo Nordisk, which makes the blockbuster
GLP-1 injectable weight-loss drug Wegovy.